ZAHIDA TAYYIB: Open Payments
NPI 1144251315 · MOUNTAIN VIEW, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 16 payments from 8 companies in 2025. Trend: 2023 $1,724 · 2024 $1,197 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $101 |
| Teva Pharmaceuticals USA, Inc. | 3 | $65 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| Lundbeck LLC | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Bausch Health US, LLC | 1 | $22 |
Products named: VRAYLAR, CAPLYTA, REXULTI, AUSTEDO XR, SPRAVATO, UZEDY, FANAPT, APLENZIN.
Industry payments across CA — which companies pay providers there.
